Capio recieves funding from the KORIL foundation, launches new study

Capio Biosciences and BioView have launched a $2.18M project to advance the use of liquid biopsy for head and neck cancer. The project is supported with a $874,000 grant from the Korea-Israel (KORIL) Industrial R&D Foundation.